[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356496-105":3,"doc-detail-356496-en":81,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-engage-study-a-randomized-trial-optimizing-uptake-of-germline-cancer-genetic-services-in-childhood-cancer-survivors","The ENGAGE study - a randomized trial optimizing uptake of germline cancer genetic services in childhood cancer survivors","","The ENGAGE trial evaluated remote, centralized telehealth genetic services to increase uptake among adult childhood cancer survivors at high risk for subsequent neoplasms and potential inherited genetic susceptibility. Participants from the Childhood Cancer Survivor Study were randomized to telehealth genetic services by phone/videoconference or usual care, with service uptake assessed using study records and a six-month status survey. Telehealth increased receipt of genetic services, counseling, and testing versus usual care, and improved uptake was linked to insurance and lower perceived testing cost.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-engage-study-a-randomized-trial-optimizing-uptake-of-germline-cancer-genetic-services-in-childhood-cancer-survivors/356496/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-engage-study-a-randomized-trial-optimizing-uptake-of-germline-cancer-genetic-services-in-childhood-cancer-survivors/356496.png","ImageObject",300,407,{"name":42,"@type":43},"Ophelia","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the primary purpose of the ENGAGE trial?","Question",{"text":63,"@type":64},"To test whether remote, centralized telehealth genetic services improve the uptake of germline cancer genetic services among childhood cancer survivors at high risk.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were participants assigned to study arms?",{"text":68,"@type":64},"After a baseline survey, participants were randomly assigned to remote telehealth genetic services via phone or videoconference, or to usual care.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key results at six months?",{"text":72,"@type":64},"Participants in the remote telehealth group had substantially higher uptake of genetic services, along with higher rates of genetic counseling and genetic testing compared with usual care.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356496,1790192728,{"code":4,"msg":82,"data":83},"success",{"doc_id":79,"user_id":84,"nickname":42,"user_avatar":85,"doc_module":4,"category_id":86,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":87,"file_id":88,"file_url":89,"file_type":90,"file_size":91,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":92,"language":93,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":94,"faqs":95,"seo_title":96,"seo_description":12,"update_tm":97,"read_time":98,"preview_page_count":33,"preview_urls":99},7971461741311,"https://ap-avatar.wpscdn.com/avatar/74000253aff267980c6?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779345379180704826",8,"Articles  \nThe ENGAGE study: a randomized trial optimizing uptake of germline cancer genetic services in childhood cancer survivors  \nTara O. Henderson,a,∗ Brian Egleston,b Sarah Howe,c Mary Ashley Allen,d Rajia Mim,c Linda G. Fleisher,b Elena B. Elkin,e Kevin C. Oeffinger,f Kevin R. Krull,g Demetrios Ofidis,c Briana McLeod,c Hannah Griffin,c Elisabeth M. Wood,c Cara N. Cacioppo,c Sarah Brown,c Melody Perpich,d Gregory T. Armstrong,g and Angela R. Bradburyc  \naAnn & Robert H. Lurie Children’s Hospital of Chicago, 225 E Chicago Ave, Chicago, IL, USA bFox Chase Cancer Center, 333 Cottman Ave, Philadelphia, PA, USA  \ncThe University of Pennsylvania, Abramson Cancer Center, 3400 Civic Center Blvd, Philadelphia, PA, USA  \ndUniversity of Chicago Medicine, 5841 S Maryland Ave, Chicago, IL, USA eColumbia University Medical Center, 722 W 168th Street, New York, NY, USAfDuke University School of Medicine, 2424 Erwin Dr, Durham, NC, USA  \ngSt. Jude Children’s Research Hospital, 262 Danny Thomas Place, Memphis, TN, USA  \nSummary  \nBackground Identifying childhood cancer survivors who are already at high risk of subsequent neoplasms and may also have an inherited genetic susceptibility is essential for effective surveillance and prevention. This trial evaluated the effectiveness of remote, centralized telehealth genetic services in increasing service uptake.  \nMethods Childhood Cancer Survivor Study (CCSS) participants at the St. Jude Research Hospital, who were ≥18 years old and survivors of a CNS tumor, sarcoma, or more than one primary cancer, were recruited for the study. After completing a baseline survey, participants were randomly assigned to one of the two arms: remote telehealth genetic services (via phone or videoconference) or usual care. Uptake of genetic services was obtained through study records and the six-month Status Survey. This trial was registered with [ClinicalTrials.gov](ClinicalTrials.gov) (NCT04455698), and accrual has closed.  \nFindings Of the 391 participants recruited, 262 were assigned to remote telehealth services (via phone or videoconference) and 129 to usual care. At six months, 43%(113/262) of participants in remote telehealth services received genetic services compared to 15%(19/129) in the usual care group (OR = 4.4, 95% CI: 2.5–8.0, p \u003C 0.0001) . Uptake of genetic counseling (42% vs. 15%, p \u003C 0.0001) and genetic testing (19% vs. 9%, p = 0.020) were higher in remote telehealth services. Factors associated with higher uptake included not having high-deductible health insurance (OR = 1.67, 95% CI: 1.00–2.91, p = 0.049) and lower perceived cost of testing (OR = 1.51, 95% CI: 1.17–1.96, p = 0.0014) . Top barriers included experiencing higher levels of depression (OR = 0.91, 95% CI: 0.85–0.98, p = 0.0067) and anxiety (OR = 0.93, 95% CI: 0.87–1.00, p = 0.036) .  \nInterpretation Remote telehealth genetic services improve genetic counseling and testing uptake in childhood cancer. Addressing remaining barriers could maximize their impact and ensure equitable access for childhood cancer survivors and their families.  \nFunding National Cancer Institute (R01-CA237369, U24-CA55727) .  \nCopyright © 2026 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license ([http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/)).  \nKeywords: Childhood cancer; Remote genetic services; Telehealth; Genetic counseling; Genetic testing  \nIntroduction  \nThe five-year survival rate for childhood cancer has exceeded 85%, resulting in a growing population of childhood cancer survivors in the United States.1 These survivors face a lifelong risk of premature mortality.2  \nSubsequent malignant neoplasms (SMNs) are the leading cause of non-relapse-related premature mortality in this population.3 While SMNs are primarily linked to prior cancer therapies,4 inherited geneticsusceptibilities can also increase the risk in both  \nThe Lancet Regional Health -Americas 2026;55: 10","cbCaiiD5iAbe7loh","https://ap.wps.com/l/cbCaiiD5iAbe7loh","pdf",3540785,11,"English","# Summary\n## Background\n## Methods\n## Findings\n## Interpretation\n## Funding\n## Keywords","[{\"question\":\"What was the primary purpose of the ENGAGE trial?\",\"answer\":\"To test whether remote, centralized telehealth genetic services improve the uptake of germline cancer genetic services among childhood cancer survivors at high risk.\"},{\"question\":\"How were participants assigned to study arms?\",\"answer\":\"After a baseline survey, participants were randomly assigned to remote telehealth genetic services via phone or videoconference, or to usual care.\"},{\"question\":\"What were the key results at six months?\",\"answer\":\"Participants in the remote telehealth group had substantially higher uptake of genetic services, along with higher rates of genetic counseling and genetic testing compared with usual care.\"}]","The ENGAGE study - a randomized trial optimizing uptake of germline cancer genetic services in childhood cancer survivors | PDF",1790125582,28,[100,104,108,112],{"page_no":22,"url":101,"width":102,"height":103},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75885e4f8475a638e1d5dbab43184999.webp",983,1310,{"page_no":26,"url":105,"width":106,"height":107},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/97f3e6080fc3946648c771b5dc003faa.webp",982,1309,{"page_no":30,"url":109,"width":110,"height":111},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5906893c5b58fe203aab738c07eda5c3.webp",981,1308,{"page_no":33,"url":113,"width":114,"height":115},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07bd5accda64f9a68aae439b4a18bf14.webp",980,1306,{"code":4,"msg":82,"data":117},[118,122,126,130,135,140,145,148,153,156,160],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":136,"doc_module":4,"doc_module_name":25,"category_name":137,"show_sort_weight":138,"slug":139},6,"Technology",50,"technology",{"id":141,"doc_module":4,"doc_module_name":25,"category_name":142,"show_sort_weight":143,"slug":144},7,"Healthcare",40,"healthcare",{"id":86,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":146,"slug":147},30,"research-report",{"id":149,"doc_module":4,"doc_module_name":25,"category_name":150,"show_sort_weight":151,"slug":152},9,"Religion & Spirituality",20,"religion-spirituality",{"id":151,"doc_module":4,"doc_module_name":25,"category_name":154,"show_sort_weight":151,"slug":155},"World Cup","world-cup",{"id":157,"doc_module":4,"doc_module_name":25,"category_name":158,"show_sort_weight":157,"slug":159},10,"Lifestyle","lifestyle",{"id":161,"doc_module":4,"doc_module_name":25,"category_name":162,"show_sort_weight":131,"slug":163},19,"General","general"]